chr8-117807339-C-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000127.3(EXT1):​c.1761G>A​(p.Glu587Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.399 in 1,613,820 control chromosomes in the GnomAD database, including 131,429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 10803 hom., cov: 32)
Exomes 𝑓: 0.40 ( 120626 hom. )

Consequence

EXT1
NM_000127.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.06

Publications

28 publications found
Variant links:
Genes affected
EXT1 (HGNC:3512): (exostosin glycosyltransferase 1) This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
EXT1 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • chondrosarcoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 8-117807339-C-T is Benign according to our data. Variant chr8-117807339-C-T is described in ClinVar as Benign. ClinVar VariationId is 255175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXT1NM_000127.3 linkc.1761G>A p.Glu587Glu synonymous_variant Exon 9 of 11 ENST00000378204.7 NP_000118.2 Q16394

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXT1ENST00000378204.7 linkc.1761G>A p.Glu587Glu synonymous_variant Exon 9 of 11 1 NM_000127.3 ENSP00000367446.3 Q16394
EXT1ENST00000437196.1 linkn.*652G>A non_coding_transcript_exon_variant Exon 8 of 10 5 ENSP00000407299.1 F8WF54
EXT1ENST00000684189.1 linkn.1228G>A non_coding_transcript_exon_variant Exon 9 of 11
EXT1ENST00000437196.1 linkn.*652G>A 3_prime_UTR_variant Exon 8 of 10 5 ENSP00000407299.1 F8WF54

Frequencies

GnomAD3 genomes
AF:
0.364
AC:
55244
AN:
151924
Hom.:
10799
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.209
Gnomad AMI
AF:
0.311
Gnomad AMR
AF:
0.506
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.418
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.425
GnomAD2 exomes
AF:
0.407
AC:
102306
AN:
251290
AF XY:
0.405
show subpopulations
Gnomad AFR exome
AF:
0.206
Gnomad AMR exome
AF:
0.536
Gnomad ASJ exome
AF:
0.398
Gnomad EAS exome
AF:
0.371
Gnomad FIN exome
AF:
0.420
Gnomad NFE exome
AF:
0.417
Gnomad OTH exome
AF:
0.429
GnomAD4 exome
AF:
0.403
AC:
588778
AN:
1461778
Hom.:
120626
Cov.:
55
AF XY:
0.401
AC XY:
291864
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.204
AC:
6820
AN:
33480
American (AMR)
AF:
0.534
AC:
23879
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.400
AC:
10455
AN:
26136
East Asian (EAS)
AF:
0.310
AC:
12302
AN:
39700
South Asian (SAS)
AF:
0.348
AC:
30049
AN:
86258
European-Finnish (FIN)
AF:
0.424
AC:
22666
AN:
53406
Middle Eastern (MID)
AF:
0.470
AC:
2708
AN:
5766
European-Non Finnish (NFE)
AF:
0.410
AC:
455472
AN:
1111928
Other (OTH)
AF:
0.405
AC:
24427
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
20544
41088
61633
82177
102721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13922
27844
41766
55688
69610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.364
AC:
55270
AN:
152042
Hom.:
10803
Cov.:
32
AF XY:
0.366
AC XY:
27193
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.209
AC:
8658
AN:
41498
American (AMR)
AF:
0.506
AC:
7715
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.407
AC:
1411
AN:
3468
East Asian (EAS)
AF:
0.372
AC:
1914
AN:
5146
South Asian (SAS)
AF:
0.338
AC:
1628
AN:
4822
European-Finnish (FIN)
AF:
0.418
AC:
4411
AN:
10554
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.415
AC:
28221
AN:
67984
Other (OTH)
AF:
0.426
AC:
896
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1726
3452
5177
6903
8629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.398
Hom.:
38209
Bravo
AF:
0.368
Asia WGS
AF:
0.319
AC:
1111
AN:
3478
EpiCase
AF:
0.428
EpiControl
AF:
0.435

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple congenital exostosis Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Exostoses, multiple, type 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.39
CADD
Benign
11
DANN
Benign
0.53
PhyloP100
4.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7837891; hg19: chr8-118819578; COSMIC: COSV65476711; API